Barbara J. Skelly

786 total citations
31 papers, 516 citations indexed

About

Barbara J. Skelly is a scholar working on Pulmonary and Respiratory Medicine, Hematology and Epidemiology. According to data from OpenAlex, Barbara J. Skelly has authored 31 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 7 papers in Hematology and 6 papers in Epidemiology. Recurrent topics in Barbara J. Skelly's work include Blood groups and transfusion (7 papers), Platelet Disorders and Treatments (5 papers) and Hepatitis B Virus Studies (4 papers). Barbara J. Skelly is often cited by papers focused on Blood groups and transfusion (7 papers), Platelet Disorders and Treatments (5 papers) and Hepatitis B Virus Studies (4 papers). Barbara J. Skelly collaborates with scholars based in United Kingdom, Portugal and United States. Barbara J. Skelly's co-authors include James W. Swann, Robin J.M. Franklin, James L. N. Wood, Katharine Hubbard, M. E. Herrtage, Bryan Winchester, M. E. Herrtage, Michael Tyler, Mary Spencer Cain and Chris Lamb and has published in prestigious journals such as PLoS ONE, Acta Neuropathologica and Experimental Biology and Medicine.

In The Last Decade

Barbara J. Skelly

27 papers receiving 489 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara J. Skelly United Kingdom 15 115 107 99 94 89 31 516
Marie E. Kerl United States 16 53 0.5× 60 0.6× 53 0.5× 74 0.8× 121 1.4× 38 770
David Jones United States 12 151 1.3× 97 0.9× 40 0.4× 39 0.4× 45 0.5× 23 617
Rebecca E. Gompf United States 14 149 1.3× 60 0.6× 48 0.5× 52 0.6× 140 1.6× 32 609
Naohito NISHII Japan 13 49 0.4× 68 0.6× 23 0.2× 94 1.0× 65 0.7× 70 442
Agnès Jamin France 15 75 0.7× 164 1.5× 62 0.6× 51 0.5× 34 0.4× 25 884
S.G. Moesgaard Denmark 15 120 1.0× 177 1.7× 32 0.3× 37 0.4× 109 1.2× 29 660
Bülent Polat Türkiye 13 36 0.3× 80 0.7× 28 0.3× 102 1.1× 61 0.7× 44 876
Alison E. Ridyard United Kingdom 14 37 0.3× 81 0.8× 102 1.0× 85 0.9× 76 0.9× 31 658
Clare Knottenbelt United Kingdom 15 40 0.3× 61 0.6× 99 1.0× 71 0.8× 51 0.6× 38 564
Matthew S. Mellema United States 17 308 2.7× 70 0.7× 23 0.2× 54 0.6× 124 1.4× 32 881

Countries citing papers authored by Barbara J. Skelly

Since Specialization
Citations

This map shows the geographic impact of Barbara J. Skelly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara J. Skelly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara J. Skelly more than expected).

Fields of papers citing papers by Barbara J. Skelly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara J. Skelly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara J. Skelly. The network helps show where Barbara J. Skelly may publish in the future.

Co-authorship network of co-authors of Barbara J. Skelly

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara J. Skelly. A scholar is included among the top collaborators of Barbara J. Skelly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara J. Skelly. Barbara J. Skelly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Skelly, Barbara J., et al.. (2024). Polyarthritis associated with clinical Hepatozoon felis infection in a domestic cat. Veterinary Record Case Reports. 12(3).
2.
Williams, Tim, et al.. (2023). Prevalence of hypercalcemia in primary hypoadrenocorticism in dogs: Multicenter, retrospective study. Journal of Veterinary Internal Medicine. 37(5). 1685–1693. 2 indexed citations
3.
Skelly, Barbara J., James W. Swann, Barbara Glanemann, et al.. (2022). Splenectomy in the management of primary immune-mediated hemolytic anemia and primary immune-mediated thrombocytopenia in dogs. Journal of Veterinary Internal Medicine. 36(4). 1267–1280. 4 indexed citations
4.
Sharman, Mellora, et al.. (2021). The use of high-dose immunoglobulin M-enriched human immunoglobulin in dogs with immune-mediated hemolytic anemia. Journal of Veterinary Internal Medicine. 36(1). 78–85. 6 indexed citations
5.
6.
Skelly, Barbara J. & James W. Swann. (2016). Canine autoimmune hemolytic anemia: management challenges. Veterinary Medicine Research and Reports. Volume 7. 101–112. 14 indexed citations
7.
Warland, James, Barbara J. Skelly, Cindy Soendersoe Knudsen, & M. E. Herrtage. (2015). Apparent Resolution of Canine Primary Hypoparathyroidism with Immunosuppressive Treatment. Journal of Veterinary Internal Medicine. 29(1). 400–404. 2 indexed citations
8.
Swann, James W. & Barbara J. Skelly. (2015). Systematic Review of Prognostic Factors for Mortality in Dogs with Immune-mediated Hemolytic Anemia. Journal of Veterinary Internal Medicine. 29(1). 7–13. 27 indexed citations
9.
Swann, James W. & Barbara J. Skelly. (2012). Systematic Review of Evidence Relating to the Treatment of Immune-Mediated Hemolytic Anemia in Dogs. Journal of Veterinary Internal Medicine. 27(1). 1–9. 33 indexed citations
10.
Skelly, Barbara J. & Robin J.M. Franklin. (2006). Mutations in genes causing human familial isolated hyperparathyroidism do not account for hyperparathyroidism in Keeshond dogs. The Veterinary Journal. 174(3). 652–654. 4 indexed citations
11.
Bexfield, Nick, R Foale, Lucy J. Davison, et al.. (2006). Management of 13 cases of canine respiratory disease using inhaled corticosteroids. Journal of Small Animal Practice. 47(7). 377–382. 26 indexed citations
12.
Skelly, Barbara J., et al.. (2006). Survey of pharmacists’ awareness of veterinary medicines. Veterinary Record. 158(7). 223–226. 5 indexed citations
13.
Neiger, Reto, et al.. (2005). Primary hyperparathyroidism in 29 dogs: diagnosis, treatment, outcome and associated renal failure. Journal of Small Animal Practice. 46(1). 10–16. 40 indexed citations
14.
Skelly, Barbara J., et al.. (2003). Use of trilostane for the treatment of pituitary‐dependent hyperadrenocorticism in a cat. Journal of Small Animal Practice. 44(6). 269–272. 29 indexed citations
15.
Skelly, Barbara J. & Robin J.M. Franklin. (2002). Recognition and Diagnosis of Lysosomal Storage Diseases in the Cat and Dog. Journal of Veterinary Internal Medicine. 16(2). 133–133. 28 indexed citations
16.
Skelly, Barbara J.. (2002). Causes, consequences and control of potassium imbalances in small animals. In Practice. 24(10). 596–604.
17.
Skelly, Barbara J. & Robin J.M. Franklin. (2002). Recognition and Diagnosis of Lysosomal Storage Diseases in the Cat and Dog. Journal of Veterinary Internal Medicine. 16(2). 133–141. 29 indexed citations
18.
Skelly, Barbara J., et al.. (1999). Identification of a 6 base pair insertion in West Highland White Terriers with erythrocyte pyruvate kinase deficiency. American Journal of Veterinary Research. 60(9). 1169–1172. 17 indexed citations
19.
Skelly, Barbara J., David R. Sargan, M. E. Herrtage, & Bryan Winchester. (1996). The molecular defect underlying canine fucosidosis.. Journal of Medical Genetics. 33(4). 284–288. 25 indexed citations
20.
Skelly, Barbara J., Martin Jeffrey, Robin J.M. Franklin, & Bryan Winchester. (1995). A new form of ovine GM1-gangliosidosis. Acta Neuropathologica. 89(4). 374–379. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marie E. Kerl Breakdown of academic impact, for papers by David Jones Breakdown of academic impact, for papers by Rebecca E. Gompf Breakdown of academic impact, for papers by Naohito NISHII Breakdown of academic impact, for papers by Agnès Jamin Breakdown of academic impact, for papers by S.G. Moesgaard Breakdown of academic impact, for papers by Bülent Polat Breakdown of academic impact, for papers by Alison E. Ridyard Breakdown of academic impact, for papers by Clare Knottenbelt Breakdown of academic impact, for papers by Matthew S. Mellema
Rankless by CCL
2026